Perry Shen to Angiogenesis Inhibitors
This is a "connection" page, showing publications Perry Shen has written about Angiogenesis Inhibitors.
Connection Strength
0.479
-
Shen P, Thomas CR, Fenstermaker J, Aklilu M, McCoy TP, Levine EA. Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer. J Gastrointest Cancer. 2014 Sep; 45(3):268-75.
Score: 0.479